by admin | Mar 21, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Frank Vinluan – MedCity News – Neurotech Pharmaceuticals’ surgically implanted cell and gene therapy, Encelto, is now FDA approved to treat macular telangectasia type 2 (MacTel). It’s the first therapy for this rare retinal degeneration disorder....
by admin | Mar 20, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Morgridge Institute for Research – MedicalXpress – Scientists at the Wisconsin National Primate Research Center (WNPRC) and the Morgridge Institute for Research at the University of Wisconsin–Madison have been at the forefront of stem cell research and...
by admin | Mar 19, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
by Laura Kelley – University of Colorado Cancer Center – Researchers at CU Anschutz Medical Campus have developed ALA-CART, a next-generation therapy aimed at improving outcomes for patients with resistant cancers. “This next-generation approach, called...
by admin | Mar 18, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By Technology Networks – A new, alternative treatment for wet AMD involves the transplantation of stem cell-derived retinal cells. Age-related macular (AMD) degeneration is a leading cause of vision impairment and blindness in the elderly population. In...
by admin | Mar 17, 2025 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions
By UCLA News – UCLA researchers are developing a gene-editing platform that aims to correct the root cause of the disease Imagine a future where treating cystic fibrosis is as simple as taking a deep breath. That’s exactly what a team of pediatric...
